Clinical trial design refers to how a study is structured—phases, endpoints, eligibility criteria, randomisation and analysis plans—which strongly influences success chances. When AI tools claim to optimise or predict based on design, clinicians and managers must understand the term to judge whether algorithms are suggesting realistic modifications or oversimplifying complex methodological and ethical trade‑offs.